On October 14, Nature Genetics published a paper by the teams of José I. Martin-Subro and Elias Campo.
The study presents a new perspective in cancer research as it integrates the data from whole epigenome and genome sequencing of chronic lymphocytic leukemia (CLL) patients. This research, directed by Iñaki Martin-Subero from Universidad de Barcelona and IDIBAPS (Barcelona, Spain), represents the first collaborative effort between two European high-impact research initiatives, such as the EU-funded Blueprint Consortium and the CLL Genome Project funded by the Spanish government. These two initiatives are set within the context of two world-wide Consortia, the International Human Epigenome Consortium and the International Cancer Genome Consortium, respectively. In the study have participated a total of 41 scientists from nine institutions associated with Blueprint Consortium and/or the CLL Genome Project.